Captrust Financial Advisors Bicycle Therapeutics PLC Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$40.12 - $59.5 $76,468 - $113,407	-1,906 Reduced 84.34%	354 $16,000
Q3 2021 Nov 16, 2021	SELL	$27.95 - $44.24 $27,950 - $44,240	-1,000 Reduced 30.67%	2,260 $94,000
Q1 2021 May 17, 2021	BUY	$19.12 - $30.25 $4,971 - $7,865	260 Added 8.67%	3,260 $97,000
Q4 2020 Feb 16, 2021	BUY	$17.95 - $21.36 $53,850 - $64,080	3,000 New	3,000 $54,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $433M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.